Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice
A mouse study found that repeated lower-dose JZL184 preserved antinociceptive and gastroprotective effects that became tolerant under higher-dose regimens. The result supports a dose-dependent experimental window, not a validated human treatment schedule.
Two disease-related models were used
Researchers examined neuropathic pain after sciatic nerve constriction and gastric hemorrhage induced by a nonsteroidal anti-inflammatory drug. JZL184 inhibits MAGL and thereby alters endogenous cannabinoid signaling. It is not THC or an ordinary cannabis extract.
Behavioral and receptor findings agreed across doses
Repeated higher doses reduced brain CB1 density and function and produced tolerance to the measured beneficial effects. Lower repeated doses maintained the effects and preserved the reported receptor measurements. Dose therefore changed both the functional outcome and the molecular adaptation pattern.
Cross-tolerance and withdrawal comparisons added limits
Higher repeated doses, but not lower doses, produced cross-tolerance to common THC effects and findings in a rimonabant-precipitated withdrawal model. These were finite-duration mouse experiments. Absence of a detected effect at the lower regimen does not establish safety at every duration, dose or endpoint.
The study supports investigating partial rather than maximal enzyme inhibition. It does not identify a human dose, establish treatment for neuropathic pain or recommend a strategy for preventing stomach injury. The compound, model and repeated-treatment conditions define the finding.
Related: interpreting cannabis tolerance claims.
Research cited
Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects. The Journal of pharmacology and experimental therapeutics (2013). doi:10.1124/jpet.112.201426. Findings discussed from the study abstract.
